# Chronic Cholesterol Exposure Disrupts Macrophage Polarization and Cytokine Secretion in a 3D Microenvironment

**Authors:** Aliyaa Ali Alzaabi, Dheyab Saleh Abubaker, Jiranuwat Sapudom, Yamanappa Hunashal, Fabio Piano, Jeremy Teo

PMC · DOI: 10.1021/acsomega.5c09175 · ACS Omega · 2026-02-05

## TL;DR

Excess cholesterol disrupts how macrophages develop and function, leading to mixed immune responses that could worsen inflammation in cholesterol-rich environments.

## Contribution

This study reveals that chronic cholesterol exposure primes monocytes and disrupts macrophage polarization, leading to noncanonical hypersecretory states.

## Key findings

- Cholesterol causes cytotoxicity in monocytes and alters their metabolism, leading to a primed state.
- Cholesterol-loaded macrophages show reduced surface markers but increased secretion of both pro-inflammatory and regulatory cytokines.
- Cholesterol exposure uncouples macrophage surface phenotype from cytokine output, promoting mixed immune responses.

## Abstract

Cholesterol is essential
for membrane organization and signaling,
but excess cholesterol is increasingly linked to immune dysregulation.
How chronic cholesterol loading shapes macrophage differentiation
and polarization remains unclear. Here, we examined the effects of
sustained cholesterol exposure on THP-1 monocytes and their polarization
within 3D collagen hydrogels. At the monocyte stage, cholesterol caused
cytotoxicity above 3 mg/mL, with an early decline in reactive oxygen
species and metabolic remodeling marked by cholesterol accumulation,
tricarboxylic acid cycle suppression, and redox imbalance. Subcytotoxic
doses preserved cell count but altered metabolic profiles, indicating
a primed state. Differentiation into uncommitted M0 macrophages produced
only minimal phenotypic changes, though modest increases in IL-10,
IFN-γ, and IP-10 suggested early functional effects. Under M1
polarization, cholesterol-loading macrophages showed reduced expression
of CD80, CD86, and HLA-DR, yet secreted higher levels of both pro-inflammatory
(IL-12p70, IFN-γ, IL-17A, MCP-1, IL-2) and regulatory (IL-10,
IL-4) cytokines. Under M2 polarization, canonical markers CD206, CD105,
and CD163 were diminished, while secretion of TGF-β1, IL-10,
TNF-α, and IL-12p70 was increased. Across both conditions, cholesterol
consistently uncoupled surface phenotype from cytokine output, producing
a noncanonical hypersecretory state. These findings suggest that cholesterol
primes monocytes and disrupts macrophage polarization, redirecting
them toward mixed, hypersecretory phenotypes independent of stimulus.
This work links cholesterol-induced metabolic stress to altered macrophage
plasticity, with implications for maladaptive immune responses in
cholesterol-rich environments.

## Linked entities

- **Proteins:** CD80 (CD80 molecule), CD86 (CD86 molecule), MRC1 (mannose receptor C-type 1), Eng (endoglin), CD163 (CD163 molecule)
- **Chemicals:** cholesterol (PubChem CID 5997)

## Full-text entities

- **Genes:** MRC1 (mannose receptor C-type 1) [NCBI Gene 4360] {aka CD206, CLEC13D, CLEC13DL, MMR, MRC1L1, bA541I19.1}, CD14 (CD14 molecule) [NCBI Gene 929], CASP1 (caspase 1) [NCBI Gene 834] {aka ICE, IL1BC, P45}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}, CXCL10 (C-X-C motif chemokine ligand 10) [NCBI Gene 3627] {aka C7, IFI10, INP10, IP-10, SCYB10, crg-2}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, CD86 (CD86 molecule) [NCBI Gene 942] {aka B7-2, B7.2, B70, BU63, CD28LG2, CD86 v6}, NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548] {aka AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, IL4 (interleukin 4) [NCBI Gene 3565] {aka BCGF-1, BCGF1, BSF-1, BSF1, IL-4}, IL13 (interleukin 13) [NCBI Gene 3596] {aka IL-13, P600}, STAT6 (signal transducer and activator of transcription 6) [NCBI Gene 100142679], IL2 (interleukin 2) [NCBI Gene 3558] {aka IL-2, TCGF, lymphokine}, ITGAM (integrin subunit alpha M) [NCBI Gene 3684] {aka CD11B, CR3A, HNA-4, MAC-1, MAC1A, MO1A}, STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 490967], CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347] {aka GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, STAT6 (signal transducer and activator of transcription 6) [NCBI Gene 6778] {aka D12S1644, HIES6, IL-4-STAT, STAT6B, STAT6C}, CD163 (CD163 molecule) [NCBI Gene 9332] {aka M130, MM130, SCARI1}, STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774] {aka ADMIO, ADMIO1, APRF, HIES}, TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, IL12B (interleukin 12B) [NCBI Gene 3593] {aka CLMF, CLMF2, IL-12B, IMD28, IMD29, NKSF}, CD68 (CD68 molecule) [NCBI Gene 968] {aka GP110, LAMP4, SCARD1}, CD83 (CD83 molecule) [NCBI Gene 9308] {aka BL11, HB15}, CD80 (CD80 molecule) [NCBI Gene 941] {aka B7, B7-1, B7.1, BB1, CD28LG, CD28LG1}
- **Diseases:** infections (MESH:D007239), COVID-19 (MESH:D000086382), cytotoxic (MESH:D064420), hypercholesterolemic (MESH:D006938), atherosclerosis (MESH:D050197), immune dysregulation (OMIM:614878), sepsis (MESH:D018805), type 2 diabetes (MESH:D003924), hypercholesterolemia (MESH:D006937), cancer (MESH:D009369), inflammation (MESH:D007249), metabolic syndrome (MESH:D024821), mitochondrial damage (MESH:D028361), metabolic dysregulation (MESH:D021081), metabolic diseases (MESH:D008659), obesity (MESH:D009765)
- **Chemicals:** aspartate (MESH:D001224), phosphocreatine (MESH:D010725), fatty acids (MESH:D005227), 3-(Trimethylsilyl)-1-propanesulfonic acid-d 6 sodium salt (-), bile acids (MESH:D001647), UFA (MESH:D005231), JC-1 (MESH:C068624), penicillin (MESH:D010406), HEPES (MESH:D006531), glutaraldehyde (MESH:D005976), PBS (MESH:D007854), NAD+ (MESH:D009243), fumarate (MESH:D005650), ROS (MESH:D017382), AMP (MESH:D000249), ATP (MESH:D000255), dihydrorhodamine 123 (MESH:C058319), citrate (MESH:D019343), glutathione (MESH:D005978), steroid hormones (MESH:D013256), glutamine (MESH:D005973), LPS (MESH:D008070), chloroform (MESH:D002725), Lipid (MESH:D008055), FITC (MESH:D016650), lactate (MESH:D019344), isocitrate (MESH:C034219), nitrogen (MESH:D009584), PMA (MESH:D013755), Triton X-100 (MESH:D017830), ADP (MESH:D000244), streptomycin (MESH:D013307), TCA (MESH:D014233), succinate (MESH:D019802), methanol (MESH:D000432), vitamin D. (MESH:D014807), phosphate (MESH:D010710), acetic acid (MESH:D019342), glutamate (MESH:D018698), Cholesterol (MESH:D002784), malate (MESH:C030298), water (MESH:D014867), phospholipid (MESH:D010743), rhodamine 123 (MESH:D020112)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** THP-1 — Homo sapiens (Human), Childhood acute monocytic leukemia, Cancer cell line (CVCL_0006), M0 — Homo sapiens (Human), Familial hypertrophic cardiomyopathy type 26, Induced pluripotent stem cell (CVCL_A6XE)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12917798/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12917798/full.md

## References

53 references — full list in the complete paper: https://tomesphere.com/paper/PMC12917798/full.md

---
Source: https://tomesphere.com/paper/PMC12917798